Furthermore, to test whether silencing SIRT6 could inhibit prostate cancer cell proliferation and metastatic ability in vivo, the SIRT6-knockdown PC3M-luc and control PC3M-luc cells were used to establish the orthotopic prostate cancer model. The gene discussed is SIRT6; the disease is Familial prostate cancer.